GET CERTIFIED IN DRUG SAFETY


RECOGNIZED COURSE QUALITY


DESIGNED FOR EXPERTS BY EXPERTS


A CASE STUDY: THE PANDEMIC INFLUENZA VACCINE


OBJECTIVES

This course aims to give you an overview of a case study from the risk communication point of view upon the emergence in 2009 of a novel influenza strain in humans and the attempts to thwart it with a vaccine as drumbeat of threat intensifies.

Influenza, communication, risk of vaccination, benefit of vaccination, outbreak, public health

 

LEARNING OUTCOMES

At the end of the course, you will be able to understand the:

  • communication mechanisms that occurred during an outbreak of a new pathogen in humans, and be informed about

  • risk/benefits of vaccination

  • complicated intersection of public health and the vaccine industry

  • scientific and economic issues that limit vaccine supply

  • logic of embracing uncertainty

  • disconnection between desire for vaccine and its use

 

120 minutes
Online based learning
English language
Certificate of Achievement
500 €
BOOK NOW

AUTHOR

avatar

Jon Cohen

Reporter
Science



COMPANIES OFFER

Short courses can be included in a training package for your team!


NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners